Compare FSEA & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSEA | LNSR |
|---|---|---|
| Founded | 1890 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 69.1M |
| IPO Year | 2022 | 2005 |
| Metric | FSEA | LNSR |
|---|---|---|
| Price | $16.86 | $6.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 14.6K | ★ 113.9K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $10.13 | $5.06 |
| 52 Week High | $17.00 | $13.43 |
| Indicator | FSEA | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 55.40 |
| Support Level | $16.85 | $5.33 |
| Resistance Level | $16.98 | $6.34 |
| Average True Range (ATR) | 0.04 | 0.36 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 57.19 | 65.17 |
First Seacoast Bancorp Inc is the savings and loan holding company. The banks business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one- to four-family residential real estate loans, commercial real estate and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. It operates in single segment of Banking Services.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.